The Recall Desk
HighFDA (Devices)·Z-0042-2020·Announced 2019-10-16

Roche Vancomycin Test Recall Due to Inaccurate Low Results

Roche Diagnostics is recalling Online TDM Vancomycin Gen.3 tests because they may produce inaccurately low sample results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a medical device that may produce inaccurate results, posing a risk of harm to patients through incorrect dosing, but no specific injuries or illnesses have been reported in the source text.

Plain-English summary

Roche Diagnostics Operations, Inc. is recalling the Online TDM Vancomycin Gen.3 (100 tests) product, catalog number 06779336190. This product is used with the cobas c 311 and cobas c 501/502 analyzers. The recall involves 27,676 units distributed across 47 states, the District of Columbia, Puerto Rico, and Guam.

The recall was initiated because the product may produce inaccurately low sample results. This issue could potentially affect the accuracy of therapeutic drug monitoring for vancomycin.

Healthcare facilities and laboratories that have this product should stop using it and contact Roche Diagnostics for instructions on how to return or dispose of the affected units.

The recalled product

Product
Online TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502
Affected units
27,676

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Lots

Distribution

Part of a larger recall action

This product is one of 2 recalled by Roche Diagnostics Operations, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →